FDA Expands Belimumab Indication to Adults With Nephritis FDA Expands Belimumab Indication to Adults With Nephritis

The approval is based on the BLISS-LN trial, in which belimumab when added to standard therapy increased response rates and prevented worsening of kidney disease in some patients with active lupus nephritis.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Alert Source Type: news